Top Markets
#1 Akedo Akedo +57.68%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.31%
#4 Cross Cross +43.97%
#5 OVERTAKE OVERTAKE +34.90%
#6 Black Phoenix Black Phoenix +34.01%
#7 Velvet Velvet +27.53%
#8 Cap Cap +15.60%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.31%
#10 Palladium Network Palladium Network +12.56%
Coin of the day
Akedo Akedo
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Rankning i aktier #39100
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Aktiekurs
$0.02243487
Senast synkroniserad: 2025-06-04
Marknadsvärde
$650.09K
Förändring (1 dag)
0.39%
Förändring (1 år)
0.00%
Land
SE
Handel Lipidor AB (publ) (LIPI)

Kategori

Healthcare
P/B-tal för Lipidor AB (publ) (LIPI)
P/B-tal per August 2026 TTM: 12.04
Enligt Lipidor AB (publ) senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 12.04. I slutet av 2023 hade företaget ett P/B-tal på -1.56.
Historik för P/B-tal för Lipidor AB (publ) från 2016 till 2026
P/B-tal vid årets slut
År P/B-tal Ändra
2026 (TTM) 12.04 0.94%
2024 11.93 -862.92%
2023 -1.56 -115.74%
2022 9.94 83.15%
2021 5.43 4.17%
2020 5.21 -57.99%
2019 12.40 47.15%
2018 8.43 -75.94%
2017 35.02 -76.02%
2016 146.04 0.00%
P/B-tal för liknande företag eller konkurrenter
Företag P/B-tal Skillnad i P/B-tal Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 32.9295 173.44%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.3617 -38.87%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -66.8597 -655.19%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -29.60%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 7.0166 -41.74%
US